Community/Retail

The American Pharmacists Association today announced the selection of the 2015 Awards and Honors Program recipients. Honorees will be officially recognized at the APhA Annual Meeting and Exposition in San Diego, March 27-30, 2015.

Community pharmacists are most concerned about below-cost reimbursement for certain generic drugs as well as exclusionary Medicare drug plans according to a survey conducted by the National Community Pharmacists Association that asked its members to help identify the organization's 2015 priorities.

New research shows that stomach sleepers with epilepsy may be at higher risk of sudden unexpected death, drawing parallels to sudden infant death syndrome in babies.

The National Association of Boards of Pharmacy® is currently reviewing .pharmacy domain name applications received from trademark holders who are registered in the Internet Corporation for Assigned Names and Numbers Trademark Clearinghouse.

Like lightening that strikes the same place twice, an armed thief successfully robbed the same pharmacy in a 1-week time frame.

Nearly 1-in-5 adults with epilepsy show symptoms of attention deficit hyperactivity disorder.

Katerina Hatzis, pharmacy student at Fairleigh Dickinson University, said the deans, staff, and faculty influence her the most.

Nadia Awad, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, suggests ways pharmacy educators can use social media to further their professional growth.

The Generic Pharmaceutical Association announced today that Ralph G. Neas, President and CEO, would be stepping down from his position in the fall of 2015.

Katerina Hatzis, a pharmacy student at Fairleigh Dickinson University, shares about her memorable service experience in Florida.

Nadia Awad, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, discusses social media's advantages for health-system pharmacists.

In response to the announcement of a new healthcare program in the State of the Union address last night, and in recognition of ongoing Congressional initiatives related to healthcare innovation, National Association of Chain Drug Stores President and CEO Steven C. Anderson, IOM, CAE issued this statement.

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions.

Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.

New Mexico State Senator Michael Padilla plans to sponsor legislation that would require retail pharmacies to start collection programs for unused medications.

FDA has unveiled a new database that houses most FDA guidance documents for regulatory professionals.

The FDA today approved Novartis' secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Avella just announced the release of patient satisfaction data, which documents the overwhelmingly positive experience that customers have had with the national specialty pharmacy.

Community pharmacists can identify and educate patients at high risk for acute kidney injury related to use of nonsteroidal anti-inflammatory drugs.

Hospira has received 510(k) regulatory clearance from the FDA for its Plum 360 medication infusion system with Hospira MedNet safety software.

A pharmacist in Hoboken, New Jersey, was arrested for allegedly stealing morphine, fentanyl, and hydromorphone from his employer, Hoboken University Medical Center.

With Americans' use of opioids increasing, a panel from the National Institutes of Health set out to measure the drugs' effectiveness in treating long-term chronic pain, and its report suggested that the risks outweigh the benefits.

Pharmacists' antibiotic dispensing practices are improved through multifaceted educational interventions.

The Walgreens Flu Indexâ„¢ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that's as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.

The Pharmacy Quality Alliance and The American Journal of Pharmacy Benefits (AJPB) are pleased to announce a partnership in which PQA will contribute a new column to each AJPB issue entitled, Medication Quality Matters.

Gedeon Richter and Actavis today announced positive results from a phase 3 trial evaluating the efficacy and safety of cariprazine, an investigational atypical antipsychotic, in preventing relapse among schizophrenia patients.

It is not inconceivable that a physician who denies requests for opiates may not receive favorable ratings, which may impact their hospital privileges.